These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 25647515

  • 1. Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells.
    Yoon JY, Cho HS, Lee JJ, Lee HJ, Jun SY, Lee JH, Song HH, Choi S, Saloura V, Park CG, Kim CH, Kim NS.
    Mol Carcinog; 2016 Apr; 55(4):387-96. PubMed ID: 25647515
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis.
    Song IS, Jun SY, Na HJ, Kim HT, Jung SY, Ha GH, Park YH, Long LZ, Yu DY, Kim JM, Kim JH, Ko JH, Kim CH, Kim NS.
    Gastroenterology; 2012 Nov; 143(5):1341-1351. PubMed ID: 22841785
    [Abstract] [Full Text] [Related]

  • 3. Tussilago farfara L. augments TRAIL-induced apoptosis through MKK7/JNK activation by inhibition of MKK7‑TIPRL in human hepatocellular carcinoma cells.
    Lee HJ, Cho HS, Jun SY, Lee JJ, Yoon JY, Lee JH, Song HH, Choi SH, Kim SY, Saloura V, Park CG, Kim NS.
    Oncol Rep; 2014 Sep; 32(3):1117-23. PubMed ID: 24969837
    [Abstract] [Full Text] [Related]

  • 4. Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
    Yoon JY, Lee JJ, Gu S, Jung ME, Cho HS, Lim JH, Jun SY, Ahn JH, Min JS, Choi MH, Jeon SJ, Lee YJ, Go A, Heo YJ, Jung CR, Choi G, Lee K, Jeon MK, Kim NS.
    Oncotarget; 2017 Dec 22; 8(68):112610-112622. PubMed ID: 29348850
    [Abstract] [Full Text] [Related]

  • 5. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
    Lee HH, Jeong JW, Lee JH, Kim GY, Cheong J, Jeong YK, Yoo YH, Choi YH.
    Oncol Rep; 2013 Sep 22; 30(3):1257-64. PubMed ID: 23828231
    [Abstract] [Full Text] [Related]

  • 6. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin J, Lv M, Li X, Li Y, Ma Y, Shen B, Zhang J.
    Hepatology; 2013 Jan 22; 57(1):140-51. PubMed ID: 22903704
    [Abstract] [Full Text] [Related]

  • 7. JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.
    Mucha SR, Rizzani A, Gerbes AL, Camaj P, Thasler WE, Bruns CJ, Eichhorst ST, Gallmeier E, Kolligs FT, Göke B, De Toni EN.
    Gut; 2009 May 22; 58(5):688-98. PubMed ID: 19106147
    [Abstract] [Full Text] [Related]

  • 8. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 9. Elevated Pressure Enhanced Trail-Induced Apoptosis in Hepatocellular Carcinoma Cells Via Erk1/2-Inactivation.
    Hong E, Lee E, Kim J, Kwon D, Lim Y.
    Cell Mol Biol Lett; 2015 Dec 15; 20(4):535-48. PubMed ID: 26124051
    [Abstract] [Full Text] [Related]

  • 10. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells.
    Song IS, Kim SU, Oh NS, Kim J, Yu DY, Huang SM, Kim JM, Lee DS, Kim NS.
    Carcinogenesis; 2009 Jul 15; 30(7):1106-14. PubMed ID: 19406930
    [Abstract] [Full Text] [Related]

  • 11. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover.
    Kim JH, Kim MJ, Choi KC, Son J.
    Int J Biochem Cell Biol; 2016 Sep 15; 78():327-334. PubMed ID: 27477310
    [Abstract] [Full Text] [Related]

  • 12. Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells.
    Lim SC, Jeon HJ, Kee KH, Lee MJ, Hong R, Han SI.
    Int J Oncol; 2016 Nov 15; 49(5):1983-1990. PubMed ID: 27665736
    [Abstract] [Full Text] [Related]

  • 13. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul 15; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 14. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
    Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H.
    World J Gastroenterol; 2009 Dec 21; 15(47):5924-35. PubMed ID: 20014456
    [Abstract] [Full Text] [Related]

  • 15. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
    Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss TS, Gregor M, Lauer UM, Bitzer M.
    Hepatology; 2006 Mar 21; 43(3):425-34. PubMed ID: 16583461
    [Abstract] [Full Text] [Related]

  • 16. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
    Kim EY, Ryu JH, Kim AK.
    Int J Oncol; 2013 Oct 21; 43(4):1291-300. PubMed ID: 23857473
    [Abstract] [Full Text] [Related]

  • 17. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin.
    Ammirante M, Di Giacomo R, De Martino L, Rosati A, Festa M, Gentilella A, Pascale MC, Belisario MA, Leone A, Turco MC, De Feo V.
    Cancer Res; 2006 Apr 15; 66(8):4385-93. PubMed ID: 16618764
    [Abstract] [Full Text] [Related]

  • 18. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, de Jong S, Kruyt FA.
    Apoptosis; 2013 Jul 15; 18(7):851-60. PubMed ID: 23456625
    [Abstract] [Full Text] [Related]

  • 19. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
    Azijli K, Yuvaraj S, Peppelenbosch MP, Würdinger T, Dekker H, Joore J, van Dijk E, Quax WJ, Peters GJ, de Jong S, Kruyt FA.
    J Cell Sci; 2012 Oct 01; 125(Pt 19):4651-61. PubMed ID: 22797920
    [Abstract] [Full Text] [Related]

  • 20. Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun/AP-1 signaling pathway.
    Jin CY, Park C, Hong SH, Han MH, Jeong JW, Xu H, Liu H, Kim GY, Kim WJ, Yoo YH, Choi YH.
    Biomed Pharmacother; 2013 May 01; 67(4):321-8. PubMed ID: 23582782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.